These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 2965119

  • 1. Microbiological properties of teicoplanin.
    Greenwood D.
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [Abstract] [Full Text] [Related]

  • 2. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC.
    Drugs; 1997 Jan; 54 Suppl 6():11-20. PubMed ID: 9474477
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.
    Greenwood D, Bidgood K, Turner M.
    J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642
    [Abstract] [Full Text] [Related]

  • 4. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC, Ribou G, Masquelier B.
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [Abstract] [Full Text] [Related]

  • 5. Endophthalmitis: gram positive ethiological agents and susceptibility to glycopeptides.
    Chisari G.
    Curr Clin Pharmacol; 2008 Sep; 3(3):153-5. PubMed ID: 18781901
    [Abstract] [Full Text] [Related]

  • 6. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C.
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the in-vitro activity of the glycopeptide antibiotic LY333328 in comparison with vancomycin and teicoplanin.
    Harland S, Tebbs SE, Elliott TS.
    J Antimicrob Chemother; 1998 Feb; 41(2):273-6. PubMed ID: 9533471
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S, Brumfitt W, Hamilton-Miller JM.
    Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
    [Abstract] [Full Text] [Related]

  • 9. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
    Kayaokay Y, Hasçelik G, Gür D, Akalin E.
    Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
    [Abstract] [Full Text] [Related]

  • 10. Glycopeptide resistance in coagulase-negative staphylococci.
    Biavasco F, Vignaroli C, Varaldo PE.
    Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
    [Abstract] [Full Text] [Related]

  • 11. In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.
    Biavasco F, Lupidi R, Varaldo PE.
    Antimicrob Agents Chemother; 1992 Feb; 36(2):331-8. PubMed ID: 1534977
    [Abstract] [Full Text] [Related]

  • 12. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 Feb; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

  • 13. Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
    Mushtaq S, Warner M, Johnson AP, Livermore DM.
    J Antimicrob Chemother; 2004 Sep; 54(3):617-20. PubMed ID: 15321983
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of the new glycopeptide decaplanin.
    Neu HC, Chin NX, Niu WW.
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of teichomycin against isolates of gram-positive bacteria.
    Fietta A, Bersani C, Mangiarotti P, Gialdroni Grassi G.
    Chemotherapy; 1983 May; 29(4):275-82. PubMed ID: 6223793
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
    Guzek A, Korzeniewski K, Nitsch-Osuch A, Rybicki Z, Prokop E.
    Adv Exp Med Biol; 2013 May; 788():125-32. PubMed ID: 23835969
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of teicoplanin against gram-positive cocci.
    Allouch P, Pina P, Chaplain C, Delarbre JM, Geffroy F, Grasmick CP, Marcolin M, Morel A, Pangon B, Rio Y, Sédaillan A.
    Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609
    [Abstract] [Full Text] [Related]

  • 18. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V.
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [Abstract] [Full Text] [Related]

  • 19. Resistance to vancomycin and teicoplanin: an emerging clinical problem.
    Johnson AP, Uttley AH, Woodford N, George RC.
    Clin Microbiol Rev; 1990 Jul; 3(3):280-91. PubMed ID: 2143434
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.